{
    "id": 23319,
    "fullName": "MET M1250T",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MET M1250T lies within the protein kinase domain of the Met protein (UniProt.org). M1250T confers a gain of function to the Met protein as demonstrated by transformation in culture, increased Met kinase activity (PMID: 28061464), and activation of the Ras signaling pathway (PMID: 11571647).",
            "references": [
                {
                    "id": 5953,
                    "pubMedId": 11571647,
                    "title": "Differential requirement of the last C-terminal tail of Met receptor for cell transformation and invasiveness.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11571647"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 12227,
                    "pubMedId": 28061464,
                    "title": "MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28061464"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4233,
        "geneSymbol": "MET",
        "terms": [
            "MET",
            "AUTS9",
            "c-Met",
            "DFNB97",
            "HGFR",
            "RCCP2"
        ]
    },
    "variant": "M1250T",
    "createDate": "06/16/2016",
    "updateDate": "09/17/2018",
    "referenceTranscriptCoordinates": {
        "id": 144797,
        "transcript": "NM_000245",
        "gDna": "chr7:g.116783420T>C",
        "cDna": "c.3749T>C",
        "protein": "p.M1250T",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10079,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Altiratinib (DCC-2701) inhibited activity of MET M1250T in an in vitro kinase assay (PMID: 26285778).",
            "molecularProfile": {
                "id": 24002,
                "profileName": "MET M1250T"
            },
            "therapy": {
                "id": 1656,
                "therapyName": "Altiratinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 7263,
                    "pubMedId": 26285778,
                    "title": "Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26285778"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24002,
            "profileName": "MET M1250T",
            "profileTreatmentApproaches": [
                {
                    "id": 9439,
                    "name": "MET Inhibitor",
                    "profileName": "MET M1250T"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 144797,
            "transcript": "NM_000245",
            "gDna": "chr7:g.116783420T>C",
            "cDna": "c.3749T>C",
            "protein": "p.M1250T",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}